13.05.2019 в 19:39 |
Non-Opioid Bupivacaine Liposome Is Effective for Post-Operative Pain First approved by the Food and Drug Administration (FDA) in 2011 for the management of post-surgical pain, bupivacaine liposome (marketed as Exparel ) is a non-opioid local analgesic that is long-acting.
<a href=http://torontogid.cf/art/lipomatous-hypertrophy/>Lipomatous hypertrophy</a>